866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

Published By :

GlobalData

Published Date : Apr 2019

Category :

Pharmaceutical

No. of Pages : 131 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan",. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Japan. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

In 2010, the Japanese pharmaceutical market was worth $67.5B, which decreased to an estimated $61.8B in 2017 at a negative Compound Annual Growth Rate (CAGR) of 2%. The Japanese medical devices market was valued at $48.3B in 2015, which increased to $52.2B in 2017. The market is expected to grow at a CAGR of 4.1% from $54.5B in 2018 to $59.4B in 2020. Regulatory reforms have led to faster and more efficient drug approval processes. This has led to international pharmaceutical companies establishing R&D centers and increasing their investments in Japan.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Japan, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Daiichi Sankyo, Astellas, Roche, Takeda, and Otsuka) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Roche, Terumo and Fujitsu)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Japan
- Porters five forces analysis for pharmaceutical and medical devices market of Japan
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunitiesand challenges to growth in the Japanese healthcare market.

Reasons to buy

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Japan, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Daiichi Sankyo, Astellas, Roche, Takeda, and Otsuka) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Roche, Terumo and Fujitsu)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Japan
- Porters five forces analysis for pharmaceutical and medical devices market of Japan
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Japanese healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Approved Biosimilars, Japan, 2018
Table 2: Top Five Therapeutic Areas by Drug Production Value ($B), Japan, 2017
Table 3: Ophthalmic Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 4: Nephrology and Urology Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2016
Table 5: In Vitro Diagnostics Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 6: Diagnostic Imaging Market, Japan, Revenue ($B), 2015-2022
Table 7: Hospital Supplies Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 8: Medical Device Classification, Japan, 2016
Table 9: Patent Fees, Japan, 2019
Table 10: Trademark Fees, Japan, 2019
Table 11: Trade Fairs, Japan, 2019

List of Figures
Figure 1: Pharmaceutical Market, Japan, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, Japan, Revenue ($B), 2015-2020
Figure 3: Country Profile, Japan, 2018
Figure 4: Pharmaceutical Market, Japan, Revenue ($B), 2010-2017
Figure 5: Pharmaceutical Market, Japan, Revenue Forecast ($B), 2018-2022
Figure 6: Pharmaceutical Exports ($B), Japan, 2010-2018
Figure 7: Top Export Partners, Japan, 2018
Figure 8: Pharmaceutical Imports ($B), Japan, 2010-2018
Figure 9: Top Import Partners, Japan, 2018
Figure 10: Pharmaceutical Supply Chain, Japan, 2019
Figure 11: Generic Drugs Market (% share), Japan, 2009-2017
Figure 12: Major Approved Biopharmaceuticals in Japan, Japan, 2016
Figure 13: Breakdown of Approved Biopharmaceuticals, Japan, 2016
Figure 14: Top 5 Therapeutic Areas by Annual Turnover ($B), Japan, 2017
Figure 15: Pharmaceutical Market, Major Players, 2017
Figure 16: Medical Device Market, Japan, Revenue ($B), 2015-2020
Figure 17: Medical Device Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Device Market, Japan, Revenue by Segment ($B), 2018
Figure 19: Ophthalmic Devices Market, Japan, Revenue ($B), 2015-2022
Figure 20: Ophthalmic Devices Market, Japan, Market Share of Major Players (%), 2015
Figure 21: Nephrology and Urology Devices Market, Japan, Revenue ($B), 2015-2022
Figure 22: Nephrology and Urology Devices Market, Japan, Market Share of Major Companies (%), 2016
Figure 23: In Vitro Diagnostics Market, Japan, Revenue ($B), 2015-2022
Figure 24: In Vitro Diagnostics Market, Japan, Market Share of Major Players (%), 2017
Figure 25: Diagnostic Imaging Market, Japan, Revenue ($B), 2015-2022
Figure 26: Diagnostic Imaging Market, Japan, Market Share of Major Players (%), 2016
Figure 27: Hospital Supplies Market, Japan, Revenue ($B), 2015-2022
Figure 28: Hospital Supplies Market, Japan, Market Share of Major Players (%), 2017
Figure 29: Diagnostic Market, Japan, Revenue ($B), 2015-2020
Figure 30: Diagnostic Market, Japan, Revenue ($B), 2021-2025
Figure 31: Medical Device Market, Japan, Revenue ($B) of Major Companies, 2017
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Japan, 2018-2019
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Japan, 2018-2019
Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Japan, 2018-2019
Figure 35: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Japan, 2018-2019
Figure 36: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Japan, 2018-2019
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Japan, 2018-2019 (by value and by number)
Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market Japan, 2018-2019(by value and by number)
Figure 39: Medical Device Market Deals (by deal value, $M), Japan, 2018
Figure 40: Medical Device Market Deals (by deal count), Japan, 2018
Figure 41: Medical Device Market Deals Share (by deal count), Japan, 2018
Figure 42: Medical Device Market Deals Share (by deal value), Japan, 2017-2018
Figure 43: Medical Device Market Deals, Japan, Top Therapy Area by Deal Value, 2018
Figure 44: Medical Device Market Deals, Japan, Top Therapy Area by Deal Number, 2018
Figure 45: Medical Device Market Deals, Japan, M&A Deals by Therapy Area, 2018
Figure 46: Medical Device Market Deals, Japan, Venture Financing Deals by Therapy Area, 2018
Figure 47: Medical Device Market Deals, Japan, Private Equity Deals by Therapy Area, 2018
Figure 48: Organization of the Health System, Japan, 2018
Figure 49: Reimbursement Pricing for New Drugs, Japan, 2018
Figure 50: Public Insurance Schemes, Japan, 2016
Figure 51: Public Insurance Schemes, People Insured by Scheme (%), Japan, 2016
Figure 52: Financial flow based on insurance flows, Japan, 2016
Figure 53: Cross-subsidy mechanism, Japan, 2017
Figure 54: Out-of-Pocket Expenditure (% of total expenditure on health), Japan, 2010-2017
Figure 55: Annual Rate of Change (%), Medicines and health fortification Price Index, Japan, 2010-2018
Figure 56: Types of Premiums, Japan, 2016
Figure 57: Pricing Policies, Japan, 2017
Figure 58: Ministry of Health, Labour and Welfare, Organization Chart, 2018
Figure 59: Organization of PSEHB and PMDA, Japan, 2018
Figure 60: Drug Approval Process, Japan, 2018
Figure 61: Drug Approval Process Timeline, Japan, 2018
Figure 62: Patent Approval Process, Japan, 2016
Figure 63: Trademark Process Timeline, Japan, 2017
Figure 64: Clinical Trial Notification Process, Japan, 2018
Figure 65: Layout of Package Insert Based on Revised Guidelines for Preparation, Japan, 2018
Figure 66: Health Care 2035, Japan, 2019
Figure 67: Health Care 2035, Japan, 2019
Figure 68: Hospitals (number), Japan, 2010-2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *